Cargando…
Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname
BACKGROUND: Recurrent episodes of Plasmodium vivax are caused by dormant liver stages of the parasite, which are not eradicated by choloroquine. Therefore, effective treatment also includes the use of primaquine (PQ). However, this secondary preventive therapy is often not effective, mostly due to p...
Autores principales: | Mac Donald-Ottevanger, M Sigrid, Adhin, Malti R, Jitan, Jeetendra Kumar, Bretas, Gustavo, Vreden, Stephen GS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743107/ https://www.ncbi.nlm.nih.gov/pubmed/29317838 http://dx.doi.org/10.2147/IDR.S135897 |
Ejemplares similares
-
Evidence of an increased incidence of day 3 parasitaemia in
Suriname: an indicator of the emerging resistance of Plasmodium
falciparum to artemether
por: Vreden, Stephen GS, et al.
Publicado: (2013) -
Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname
por: Vreden, Stephen GS, et al.
Publicado: (2016) -
Gold mining areas in Suriname: reservoirs of malaria resistance?
por: Adhin, Malti R, et al.
Publicado: (2014) -
Malaria serology data from the Guiana shield: first insight in IgG antibody responses to Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae antigens in Suriname
por: Labadie-Bracho, Mergiory Y., et al.
Publicado: (2020) -
Status of potential PfATP6 molecular markers for artemisinin resistance in Suriname
por: Adhin, Malti R, et al.
Publicado: (2012)